Anti-Atopic Effect of Scutellaria baicalensis and Raphanus sativus on Atopic Dermatitis-like Lesions in Mice by Experimental Verification and Compound-Target Prediction

Author:

Lee Jeongmin1,Seo Yun-Soo23,Lee A Yeong3ORCID,Nam Hyeon-Hwa23ORCID,Ji Kon-Young24ORCID,Kim Taesoo4,Lee Sanghyun5ORCID,Hyun Jin Won6ORCID,Moon Changjong1ORCID,Cho Yongho1,Jung Bokyung1,Kim Joong Sun1ORCID,Chae Sungwook24ORCID

Affiliation:

1. BK21 FOUR Program, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Republic of Korea

2. Center for Companion Animal New Drug Development, Jeonbuk Branch, Korea Institute of Toxicology, Jeongeup 56212, Republic of Korea

3. Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, 111, Geonjae-ro, Naju-si 58245, Republic of Korea

4. KM Convergence Research Division, Korea Institute of Oriental Medicine, 1672 Yuseongdae-ro, Yuseong-gu, Daejeon 34054, Republic of Korea

5. Department of Plant Science and Technology, Chung-Ang University, Anseong 17546, Republic of Korea

6. Jeju Research Center for Natural Medicine, Department of Biochemistry, College of Medicine, Jeju National University, Jeju 63243, Republic of Korea

Abstract

Scutellaria baicalensis Georgi and Raphanus Sativus Linne herbal mixture (SRE) is a Chinese herbal medicine. In this study, we aimed to evaluate the therapeutic efficacy of SRE as an active ingredient for 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD) and to predict the underlying therapeutic mechanisms and involved pathways using network pharmacological analysis. Treatment with SRE accelerated the development of AD-like lesions, improving thickness and edema of the epidermis. Moreover, administering the SRE to AD-like mice suppressed immunoglobulin E and interleukin-4 cytokine and reduced T lymphocyte differentiation. In silico, network analysis was used to predict the exact genes, proteins, and pathways responsible for the therapeutic effect of the SRE against DNCB-induced AD. These results indicated that the SRE exerted protective effects on the DNCB-induced AD-like model by attenuating histopathological changes and suppressing the levels of inflammatory mediators. Therefore, the SRE can potentially be a new remedy for improving AD and other inflammatory diseases and predicting the intracellular signaling pathways and target genes involved. This therapeutic effect of the SRE on AD can be used to treat DNCB-induced AD and its associated symptoms.

Funder

Ministry of Education

National Research Council of Science

Publisher

MDPI AG

Reference66 articles.

1. Update on therapy of atopic dermatitis;Hanifin;J. Allergy Clin. Immunol.,1999

2. Mast cells and inflammation;Theoharides;Biochim. Biophys. Acta (BBA)-Mol. Basis Dis.,2012

3. Atopic dermatitis: A disease caused by innate immune defects?;Agnihothri;J. Investig. Dermatol.,2009

4. Tokura, Y. (2016). Immunology of the Skin: Basic and Clinical Sciences in skin Immune Responses, Springer.

5. Hemrajani, C., Negi, P., Parashar, A., Gupta, G., Jha, N.K., Singh, S.K., Chellappan, D.K., and Dua, K. (2022). Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. Biomed. Pharmacother., 147.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3